This new observational study is part of a broader literature suggesting that vitamin B3 (niacin & niacinamide) might prevent and treat glaucoma.
The mechanism almost certainly involves NAD.
A small 2020 randomized trial in humans testing the niacinamide form of vitamin B3 produced promising results in patients with glaucoma:
Centre for Eye Research Australia | CERAVitamin B3 shows promise for glaucoma patients in world-first clinical trial | CERAA world-first clinical trial led by the Centre for Eye Research Australia has shown that vitamin B3 (nicotinamide) could play an important role in protecting against nerve cell damage that leads to blindness in glaucoma.cera.org.au
A larger clinical trial is currently underway to determine if these positive results can be replicated:
ucl.ac.ukVitamin b3 trialled glaucoma treatmentucl.ac.ukSee these previous posts on vitamin B3 and glaucoma:
↪ Nicotinic acid (vitamin B3) may prevent or treat glaucoma, possibly via NAD
↪ Vitamin B3 forms and NAD: strong evidence in skin cancer, only preliminary in glioblastoma




